Powder volume of linezolid
The powder volume (also called powder displacement value or reconstitution volume) for linezolid injection is not a standard pharmacopeial parameter since linezolid for injection comes as a ready-to-use solution (2 mg/mL in 100 mL or 300 mL bags), not as a powder for reconstitution.
However, if you are referring to linezolid oral suspension (powder for oral suspension), the displacement volume is relevant there.
Searching sources...
Reading File
Searching the Web
linezolid powder volume displacement value oral suspension reconstitution
Finding Sources
Reading Web Page
https://labeling.pfizer.com/ShowLabeling.aspx?id=13402
Here is the complete answer on linezolid powder volume (displacement volume):
Linezolid - Powder Volume (Displacement Volume)
ZYVOX Oral Suspension (100 mg/5 mL)
The official Pfizer prescribing information (ZYVOX for Oral Suspension) provides the following reconstitution data:
| Parameter | Value |
|---|---|
| Diluent added (distilled water) | 123 mL |
| Final constituted volume | 150 mL |
| Powder volume (displacement volume) | 150 - 123 = 27 mL |
| Concentration after constitution | 100 mg / 5 mL |
| Total drug content per bottle | 3,000 mg (3 g) |
Calculation:
Powder volume = Final volume - Volume of diluent added = 150 mL - 123 mL = 27 mL
Reconstitution Instructions
- Gently tap the bottle to loosen the powder
- Add 123 mL of distilled water in two portions
- After the first half, shake vigorously to wet all powder
- Add the second half and shake vigorously for a uniform suspension
- Do not shake before use - gently invert 3-5 times
- Store at room temperature; use within 21 days after constitution
Key Notes
- Linezolid IV (2 mg/mL bags) is a ready-to-use solution - there is no powder to reconstitute, so powder volume is not applicable for the IV formulation
- Powder volume is relevant only for the oral suspension granule formulation
- The Pfizer/ZYVOX prescribing information is the authoritative source for these values
Sytup of linezolid calculation
Linezolid syrup (oral suspension) is available as 100 mg/5 mL after reconstitution. Dose calculations depend on the patient's weight and indication - typically 10 mg/kg every 8-12 hours in children.
Searching sources...
Finding Sources
Searching the Web
linezolid oral suspension 100mg/5ml dose calculation pediatric adults
Reading Web Page
https://www.drugs.com/dosage/linezolid.html
Here is a full breakdown of linezolid syrup (oral suspension) dose calculations:
Linezolid Oral Suspension - Dose Calculation
Available concentration: 100 mg / 5 mL (= 20 mg/mL)
Step 1 - Find the Dose (by Age Group)
| Patient Group | Dose | Frequency |
|---|---|---|
| Preterm neonate (<34 wks gestation, age <7 days) | 10 mg/kg | Every 12 hours |
| Term neonate (≥34 wks gestation, age <7 days) | 10 mg/kg | Every 8 hours |
| Infants & children (7 days - 11 years) | 10 mg/kg | Every 8 hours |
| Uncomplicated skin infection (5-11 years) | 10 mg/kg | Every 12 hours |
| Adolescents & adults (≥12 years) | 600 mg fixed | Every 12 hours |
| Uncomplicated skin infection (adults) | 400 mg fixed | Every 12 hours |
Maximum dose: 600 mg per dose (even in children)
Step 2 - Calculate the Dose in mg
Dose (mg) = Weight (kg) × 10 mg/kg
Example: Child weighing 20 kg
Dose = 20 kg × 10 mg/kg = 200 mg per dose
Step 3 - Calculate the Volume to Give
Volume (mL) = Dose required (mg) ÷ Concentration (mg/mL) Volume = Dose (mg) ÷ 20 mg/mL
Or using the labeled strength:
Volume (mL) = [Dose (mg) ÷ 100] × 5
Example: 200 mg dose
Volume = 200 ÷ 20 = 10 mL per dose
Worked Examples
| Weight | Dose (10 mg/kg) | Volume (at 100 mg/5 mL) | Frequency |
|---|---|---|---|
| 5 kg (infant) | 50 mg | 2.5 mL | q8h |
| 10 kg (toddler) | 100 mg | 5 mL | q8h |
| 15 kg | 150 mg | 7.5 mL | q8h |
| 20 kg | 200 mg | 10 mL | q8h |
| 30 kg | 300 mg | 15 mL | q8h |
| 60 kg (adult equivalent) | 600 mg (cap) | 30 mL | q12h |
Quick Formula Summary
Dose (mg) = Weight (kg) × 10
Volume (mL) = Dose (mg) ÷ 20
OR
Volume (mL) = Weight (kg) × 10 ÷ 20
= Weight (kg) ÷ 2
So for a child: Volume in mL = Half the body weight in kg (for 10 mg/kg dose at 20 mg/mL)
Duration of Treatment
| Indication | Duration |
|---|---|
| Nosocomial / community-acquired pneumonia | 10-14 days |
| Complicated skin & soft tissue infections | 14-28 days |
| VRE infections | 14-28 days |
| Uncomplicated skin infections | 10-14 days |
Source: ZYVOX Prescribing Information (Pfizer, 2024)
Vancomycin dose
Vancomycin dosing is weight-based (15-20 mg/kg/dose) for serious infections, given IV every 6-12 hours depending on renal function. Monitoring of trough levels or AUC/MIC is essential.
Searching sources...
Finding Sources
Searching the Web
vancomycin dosing guidelines 2024 adult pediatric AUC monitoring
Reading File
Here is a complete vancomycin dosing guide:
Vancomycin Dosing
Available Formulations
- IV: 500 mg, 1 g, 1.5 g, 2 g vials (powder for reconstitution)
- Oral capsules: 125 mg, 250 mg (for C. difficile only - NOT absorbed systemically)
- Concentration after reconstitution: typically diluted to 5 mg/mL for infusion
Adult IV Dosing
| Indication | Dose | Frequency |
|---|---|---|
| Serious infections (MRSA, endocarditis, bacteremia) | 25-30 mg/kg loading, then 15-20 mg/kg | q8-12h |
| Standard starting dose (normal renal function) | 45-60 mg/kg/day in divided doses | q8-12h |
| Traditional regimen (mild-moderate) | 1 g (~30 mg/kg/day) | q12h |
| Critically ill / loading dose | 20-25 mg/kg | Single loading dose |
| Meningitis | 30-60 mg/kg/day | 2-3 divided doses |
| Maximum single dose | 3 g | - |
Pediatric IV Dosing
| Age Group | Dose | Frequency |
|---|---|---|
| Neonates (<1 week, term) | 15 mg/kg | q12h |
| Neonates (1-4 weeks) | 10-15 mg/kg | q8h |
| Infants & children (>1 month) | 10-15 mg/kg | q6h |
| Children (serious infections) | 40-60 mg/kg/day | 3-4 divided doses |
| Max pediatric dose | 60 mg/kg/day (not to exceed adult dose) | - |
Oral Vancomycin (C. difficile ONLY)
| Indication | Dose | Frequency |
|---|---|---|
| C. difficile colitis | 125 mg | q6h x 10 days |
| Severe/recurrent CDI | 500 mg | q6h x 10 days |
Oral vancomycin is NOT absorbed - it acts locally in the gut only.
Renal Dose Adjustment (IV)
| CrCl (mL/min) | Dosing Interval |
|---|---|
| >90 | q6-8h |
| 50-90 | q12h |
| 10-50 | q24-48h |
| <10 (no dialysis) | q48-96h (monitor levels) |
| Hemodialysis | 1 g loading, then 500 mg after each session |
Therapeutic Drug Monitoring (TDM) - Current Guidelines
The ASHP/IDSA/PIDS 2020 guidelines shifted from trough-only monitoring to AUC-guided dosing:
| Parameter | Target |
|---|---|
| AUC/MIC ratio (preferred) | 400-600 mg·h/L (assuming MIC = 1 mg/L) |
| Trough (if AUC not available) | 15-20 mcg/mL (serious infections) |
| Peak | Keep <60 mcg/mL (to avoid ototoxicity) |
| Trough timing | Draw 30 min before next dose |
| Peak timing | Draw 1-2 hours after infusion ends |
Infusion Rate (Important)
- Infuse over at least 60 minutes (preferably 1-2 hours)
- For doses >1 g: infuse over 1.5-2 hours
- Rapid infusion causes Red Man Syndrome (histamine-mediated flushing, erythema of face/neck/upper torso)
- Prevented by slowing infusion or pre-treating with diphenhydramine
Quick Dose Calculation Example
Patient: 70 kg adult, normal renal function, MRSA bacteremia
Loading dose = 70 kg × 25 mg/kg = 1,750 mg (round to 1,750 mg or 2 g) Maintenance = 70 kg × 15-20 mg/kg = 1,050-1,400 mg q12h (round to 1 g - 1.5 g q12h) Total daily dose = 45-60 mg/kg/day = 3,150-4,200 mg/day ÷ by frequency
Sources: - Katzung's Basic & Clinical Pharmacology, 16th Ed., p.1257 | - Harrison's Principles of Internal Medicine, 22E | ASHP/IDSA Vancomycin Guidelines 2020
Formulations
Based on our conversation context, you're asking about vancomycin formulations.
Vancomycin comes as IV powder for reconstitution, oral capsules, and oral solution. Let me get the complete details.
Searching sources...
Finding Sources
Searching the Web
vancomycin all formulations available strengths oral IV topical 2024
Reading Web Page
https://reference.medscape.com/drug/firvanq-vancocin-vancomy…
Here is a complete breakdown of all vancomycin formulations:
Vancomycin - All Formulations
1. IV Injection - Lyophilized Powder for Reconstitution (Generic)
The most commonly used form in hospitals.
| Vial Strength | Reconstitution | Resulting Concentration |
|---|---|---|
| 500 mg | Add 10 mL sterile water | 50 mg/mL |
| 1 g | Add 20 mL sterile water | 50 mg/mL |
| 1.5 g | Add 30 mL sterile water | 50 mg/mL |
| 5 g (bulk) | Add 100 mL sterile water | 50 mg/mL |
After reconstitution, further dilute in 100-250 mL of NS or D5W before infusing. Final infusion concentration: typically 5 mg/mL.
2. IV Injection - Premixed Ready-to-Use Bags (GALAXY containers)
Frozen, iso-osmotic, premixed - thaw before use. No reconstitution needed.
| Strength | Volume | Concentration | Diluent |
|---|---|---|---|
| 500 mg | 100 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 750 mg | 150 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 1 g | 200 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 1.25 g | 250 mL | 5 mg/mL | D5W or 0.9% NaCl |
| 1.5 g | 300 mL | 5 mg/mL | D5W or 0.9% NaCl |
3. IV Injection - Ready-to-Infuse Solution (Tyzavan)
Brand-name, ready-to-infuse formulation. Same strengths as GALAXY bags. No preparation needed.
4. Oral Capsules - Vancocin (Brand) / Generic
Used ONLY for GI infections - NOT absorbed systemically.
| Strength |
|---|
| 125 mg capsules |
| 250 mg capsules |
- Indications: C. difficile-associated diarrhea, staphylococcal enterocolitis
- Store at 15-30°C
5. Powder for Oral Solution - Firvanq (Kit)
Convenient for patients who cannot swallow capsules (pediatric/elderly).
| Strength | Form |
|---|---|
| 25 mg/mL | After constitution |
| 50 mg/mL | After constitution |
- Indications: same as oral capsules (C. difficile, staphylococcal enterocolitis)
- Available for adults and pediatric patients <18 years
Summary Table
| Formulation | Brand | Route | Use |
|---|---|---|---|
| Lyophilized powder vials (500 mg, 1 g, 1.5 g, 5 g) | Generic | IV only | Systemic infections (MRSA, endocarditis, etc.) |
| Premixed frozen bags (500 mg - 1.5 g / 5 mg/mL) | Generic (GALAXY) | IV only | Systemic infections |
| Ready-to-infuse solution | Tyzavan | IV only | Systemic infections |
| Capsules (125 mg, 250 mg) | Vancocin | Oral only | C. diff, staphylococcal enterocolitis |
| Powder for oral solution (25 & 50 mg/mL) | Firvanq | Oral only | C. diff, staphylococcal enterocolitis |
Key Points
- IV vancomycin is NOT given orally - the premixed bags are strictly IV only
- Oral vancomycin is NOT absorbed - it stays in the gut and has no systemic effect
- The two routes serve completely different purposes and are NOT interchangeable
- IV infusion rate: ≤10 mg/min (or over at least 60 minutes) to prevent Red Man Syndrome
This is a shared conversation. Sign in to Orris to start your own chat.